Related Experiment Videos
[Hyperbilirubinemia in neonates associated with total parenteral nutrition]
Insights
Neonatal hyperbilirubinemia (HB) during total parenteral nutrition (TPN) is common, especially with infections or obstructive intestinal diseases. Higher caloric intake (>110 kcal/kg/day) also increased HB risk in neonates.
Area of Science:
- Neonatology
- Pediatric Gastroenterology
- Clinical Nutrition
Background:
- Hyperbilirubinemia (HB) is a significant concern in neonates receiving total parenteral nutrition (TPN).
- Understanding the risk factors for HB in this vulnerable population is crucial for optimizing TPN protocols.
Purpose of the Study:
- To investigate the pathogenesis and clinical factors associated with hyperbilirubinemia in neonates undergoing TPN.
- To identify specific conditions and nutritional parameters that influence the development of HB during TPN.
Main Methods:
- A retrospective clinical study analyzing data from 77 neonates who received TPN for over two weeks between 1971 and 1982.
- Comparison of HB incidence based on the presence of infection, obstructive intestinal diseases, caloric intake, gestational age, birth weight, TPN duration, and fasting periods.
Main Results:
- 57.2% of neonates developed HB within the first month of TPN.
- HB incidence was significantly higher in neonates with dominant infections (87.5%) compared to those without (35.6%).
- Obstructive intestinal diseases and caloric intake exceeding 110 kcal/kg/day were associated with increased HB occurrence.
Conclusions:
- Infection and obstructive intestinal diseases are major contributors to hyperbilirubinemia in neonates on TPN.
- Caloric load is a significant factor in TPN-associated hyperbilirubinemia, while gestational age, birth weight, and TPN duration showed no significant influence.
Abstract:
Clinical studies on the pathogenesis of hyperbilirubinemia (HB) in neonates during total parenteral nutrition (TPN) were performed. From 1971 to 1982, 77 neonates underwent TPN for more than 2 weeks in our institutions. Forty-four of them (57.2%) developed HB during the first one month of life. Twenty eight of 32 patients (87.5%) with dominant infection developed hB, while only 16 of 45 (35.6%) without infection developed HB. Patients with any kind of obstructive intestinal diseases evoked HB more commonly than patients with other diseases. In addition, HB occurred more often in the patients receiving more than 110 kcal/kg/day than those receiving less than that. Gestational ages, birth weights, the duration of TPN and fasting periods had no significant influence on the occurrence of HB.